市場調查報告書
商品編碼
1558343
2030 年行動醫療應用市場預測:按產品類型、平台、設備、技術、應用程式、最終用戶和地區進行的全球分析mHealth Apps Market Forecasts to 2030 - Global Analysis By Product Type (Medical Apps, Fitness Apps and Other Product Types), Platform, Device, Technology, Application, End User and By Geography |
根據 Stratistics MRC 的數據,2024 年全球行動醫療應用市場規模為 378 億美元,預計在預測期內將以 16.9% 的複合年成長率成長,到 2030 年達到 966 億美元。
行動醫療應用程式是一款支援醫療保健服務和資訊的行動應用程式。提供健康資料收集、疾病管理、健康教育、遠端醫療、健康監測等多種健康相關功能。行動醫療應用程式的好處包括增加可近性、提高病人參與、增加便利性和成本效益。這些應用程式可以幫助管理慢性病、提供健康教育、實現遠端諮詢以及追蹤健身目標。它也減少了親自就診的需要。
根據《行動經濟2023》報告,智慧型手機普及率預計在2022年達到76%,2030年達到92%。
健康監測需求增加
糖尿病、高血壓和心臟病等慢性病的盛行率不斷上升,需要透過行動醫療應用程式進行持續的健康監測。這些工具可幫助患者追蹤生命徵象、管理症狀並更有效地管理治療。預防性醫療保健也變得越來越重要,行動醫療應用程式可以追蹤健身、營養、睡眠和整體健康。
網路威脅的有吸引力的目標
行動醫療應用程式容易受到網路犯罪分子的攻擊,從而導致未授權存取、身分盜竊、財務損失和隱私侵犯。網路攻擊可能會損害健康資料的完整性,導致臨床測量結果被操縱、誤診和不適當的治療。受害者會經歷焦慮、創傷和脆弱,這可能會使現有的心理健康狀況惡化。因此,行動醫療應用程式必須保持警惕,保護敏感的健康資料。
行動訂閱和網路普及率的增加
行動醫療應用程式正在擴大其覆蓋範圍,涵蓋農村和服務不足的人群。這種可訪問性可以實現即時遠端患者監護,提高護理品質並促進及時干預。智慧型手機和網路存取的普及導致行動醫療應用程式下載量激增,達到 37 億次,顯示數位醫療產業的收益顯著成長。這種利用率的成長對於慢性病管理特別有益。
發展中地區的技術壁壘
新興市場中的數位落差以及設備和連接分佈的不平等阻礙了行動醫療應用程式的採用,限制了潛在的用戶群和市場成長。這引起了人們對公平醫療保健服務的擔憂。此外,衛生系統準備不足以及行動醫療應用程式與現有醫療保健系統之間缺乏互通性進一步阻礙了採用。這些挑戰加劇了數位鴻溝,並阻礙了行動醫療解決方案的有效性和擴充性。
COVID-19 的影響
疫情導致遠距醫療需求激增,行動醫療應用程式對於症狀追蹤、遠端醫療諮詢和慢性病管理已變得至關重要。政府和醫療機構提高了對這些應用程式的認知,並促進了公眾對它們的採用。這場危機改變了人們對數位醫療技術的看法,使它們對醫療保健提供者和患者來說更容易接受和必要,並可能影響未來的醫療保健服務模式。
醫療應用程式行業預計將在預測期內成為最大的行業
醫療應用程式預計在預測期內將成長最快,因為它們透過遠端監控、用藥提醒和健康追蹤來協助慢性病管理。慢性病的增加將推動對行動醫療解決方案的需求。醫療應用程式還使用戶能夠控制自己的健康,並透過遠端醫療諮詢和健康追蹤等功能帶來更好的健康結果,從而提高用戶參與度。
預計慢性病管理領域在預測期內的複合年成長率最高。
慢性病需要自我管理工具,例如用藥提醒、症狀追蹤和健康資料登錄,導致應用程式使用量增加和市場成長。行動醫療應用程式正在擴展到包括糖尿病、高血壓和心血管問題等疾病,近一半的可用應用程式是針對這些疾病設計的。
由於行動使用量和醫療保健支出的增加、5G 網路的成長以及政府措施和資金的增加,預計北美將在預測期內佔據最大的市場佔有率。根據世界銀行統計,2022年北美地區人均國民衛生支出約1,1,076.74美元。此外,該地區慢性病盛行率的上升和老年人口的增加預計將推動市場成長。
在亞太地區,慢性病和感染疾病發病率不斷上升、醫療保健成本不斷上升、醫院服務管理效率低下以及老年人口不斷增加,正迫使政府和醫療保健提供者開發新的醫療保健服務模式,預計該模式將在本世紀達到最高的複合年成長率。例如,2024年1月,京東醫療在其應用程式中推出了新的養老頻道,為滿足中國老齡化人口的各種醫療需求提供綜合平台。
According to Stratistics MRC, the Global mHealth Apps Market is accounted for $37.8 billion in 2024 and is expected to reach $96.6 billion by 2030 growing at a CAGR of 16.9% during the forecast period. mHealth Apps are mobile applications that support healthcare services and information. They offer various health-related functionalities, such as health data collection, disease management, health education, telemedicine, and health monitoring. Benefits of mHealth apps include increased accessibility, improved patient engagement, enhanced convenience, and cost-effectiveness. These apps help manage chronic conditions, provide health education, enable remote consultations, and track fitness goals. They also reduce the need for in-person healthcare visits.
According to the Mobile Economy 2023 report, smartphone penetration was at 76% in 2022 and is predicted to reach 92% by 2030.
Increased demand for health monitoring
The increasing prevalence of chronic diseases like diabetes, hypertension, and heart disease necessitates continuous health monitoring through mHealth apps. These tools help patients track vital signs, manage symptoms, and manage treatment more effectively. Preventive healthcare is also gaining importance, with mHealth apps tracking fitness, nutrition, sleep, and overall wellness.
Attractive targets for cyber threats
mHealth apps are vulnerable to cybercriminals, leading to unauthorized access to personal health information (PHI), identity theft, financial loss, and privacy violations. Cyberattacks can compromise health data integrity, causing manipulated clinical measurements, misdiagnoses, and inappropriate treatments. Victims may experience anxiety, trauma, and vulnerability, which can exacerbate existing mental health conditions. Therefore, mHealth apps must be vigilant to protect sensitive health data.
Increase in mobile subscriptions and internet penetration
mHealth apps have expanded their reach, reaching underserved populations in rural areas. This accessibility allows for real-time remote patient monitoring, improving care quality and facilitating timely interventions. The proliferation of smartphones and internet access has led to a surge in mHealth app downloads, reaching 3.7 billion, indicating significant revenue growth in the digital health sector. This growth in usage is particularly beneficial for chronic disease management.
Technological barriers in developing regions
The digital divide and unequal distribution of devices and connectivity in developing regions hinder the widespread use of mobile health apps, limiting their potential user base and market growth. This raises concerns about equitable healthcare delivery. Additionally, inadequate health system readiness and lack of interoperability between mHealth apps and existing healthcare systems further hinder adoption. These challenges contribute to the digital divide and hinder the effectiveness and scalability of mHealth solutions.
Covid-19 Impact
The pandemic led to a surge in demand for remote healthcare, with mHealth apps becoming crucial for symptom tracking, telemedicine consultations, and managing chronic conditions. Governments and health organizations promoted these apps to raise awareness and encourage public adoption. The crisis altered perceptions of digital health technologies, making them more acceptable and necessary for healthcare providers and patients, potentially impacting future healthcare delivery models.
The medical apps segment is expected to be the largest during the forecast period
The medical apps is expected to be the largest during the forecast period as they aid in chronic disease management through remote monitoring, medication reminders, and health tracking. The rise in chronic conditions drives demand for mHealth solutions. Medical apps also boost user engagement by empowering users to take control of their health, leading to better health outcomes through features like telemedicine consultations and health tracking.
The chronic disease management segment is expected to have the highest CAGR during the forecast period
The chronic disease management segment is expected to have the highest CAGR during the forecast period as chronic diseases demand self-management tools like medication reminders, symptom tracking, and health data logging, leading to increased app usage and market growth. mHealth apps have expanded to include diseases like diabetes, hypertension, and cardiovascular issues, with nearly half of available apps designed for these conditions.
North America is projected to hold the largest market share during the forecast period owing to increasing mobile usage & healthcare expenditure, growing 5G networks, and rising number of government initiatives & funding are driving the regional market growth. As per the World Bank statistics, the per capita national health expenditure in North America in 2022 was about USD 11,076.74. Furthermore, rising chronic disease prevalence and increasing geriatric population in the region are expected to support market growth.
Asia Pacific is projected to witness the highest CAGR over the forecast period owing to increasing incidence of chronic & infectious diseases, rising healthcare expenditure, ineffective hospital service management, and a growing elderly population, are compelling governments & healthcare providers to develop new healthcare delivery models. For instance, in January 2024, JD Health introduced a new elderly care channel on its app to provide a comprehensive platform for the various healthcare needs of China's aging population.
Key players in the market
Some of the key players in mHealth Apps market include Abbott, AirStrip Technologies, Inc., Apple Inc, AstraZeneca, AT&T, Boston Scientific Corporation, Fitbit Inc, Google Inc., Johnson & Johnson Services, Inc., Livongo Health, Novartis AG, Omada Health, Inc., Omron Healthcare, Inc, Orange, Pfizer Inc., Qualcomm Technologies, Inc., Samsung Electronics Co. Ltd., Sanofi, Teladoc Health, Inc. and Veradigm LLC
In September 2024, Abbott announced U.S. availability of Lingo(TM), the company's first continuous glucose monitoring system available without a prescription. Lingo is based on Abbott's world-leading FreeStyle Libre(R) continuous glucose monitoring technology1, now used by more than 6 million people with diabetes globally1.
In August 2024, Abbott announced the expansion of its Pure Bliss(TM) by Similac(R) line of organic, and European-made infant formulas that give parents a variety of products to meet specific formula preferences.
In June 2024, Boston Scientific Corporation announced it has entered into a definitive agreement to acquire Silk Road Medical, Inc. (Nasdaq: SILK), a medical device company that has developed an innovative platform of products to prevent stroke in patients
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.